Navigation Links
Neurocrine Mourns the Passing of Founder and Board Member Wylie Vale, Ph.D.
Date:1/6/2012

SAN DIEGO, Jan. 7, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) is sad to announce that its academic founder and member of the Board of Directors, Wylie W. Vale, Ph.D. passed away earlier this week.  He was a thoughtful leader with an incredible scientific mind who will be sorely missed.  "Wylie's intellect was matched by his terrific wit and disarming good nature.  He was a good friend," said Kevin Gorman, President and Chief Executive Officer of Neurocrine.  The entire Neurocrine team mourns his passing and extends its sympathies to the Vale family.

 

 


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
2. Neurocrine Biosciences Reports First Quarter 2008 Results
3. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
4. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
5. Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain
6. Neurocrine Biosciences Presents Elagolix Data
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
8. Neurocrine Biosciences Reports Third Quarter 2009 Results
9. Neurocrine Advances VMAT2 Inhibitor Program
10. Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference
11. Neurocrine Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ViewRay, Inc. (Nasdaq: VRAY) announced today that the German Research ... Germany , has purchased a MRIdian Linac ... Heidelberg as part of its initiative for MRI-based radiation ... headed by Medical Director and Professor Jürgen Debus, M.D., ... Cancer Research Center (DKFZ), the Heidelberg Heavy Ion Center ...
(Date:1/19/2017)... New Review of Safinamide ... Symptoms and Motor Complications in Mid- to Late-stage ... ... C Warren Olanow ... 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late Published ...
(Date:1/19/2017)... CLEVELAND , Jan. 18, 2017  ViewRay, ... the world,s first and only clinical MRI-guided radiation ... gross proceeds of approximately $26.1 million through a ... Puissance Capital Management led the financing and was ... OrbiMed Advisors, LLC and Kearny Venture Partners, and ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... WhoHaha , a digital ... the American Heart Association (AHA) to produce a three-part video series that uses humor ... as part of the launch of AHA’s Healthy For Good™ movement, which is designed ...
(Date:1/19/2017)... ... , ... Cosmetic Town, an online plastic surgery community, begins 2017 with an ... for their readers to get the information they desire. The procedures are now listed ... used on those particular areas. , “We are excited to streamline our listings in ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... Lipids,” with Gattefossé, the leader in innovative excipients and drug delivery solutions to ...
(Date:1/19/2017)... ... January 19, 2017 , ... MB ... a new $11,250,000 senior credit facility to Sunrise, Florida-based Management Health Systems, LLC, ... used to facilitate a recapitalization of MedPro led by Harren Equity Partners. ...
(Date:1/19/2017)... California (PRWEB) , ... January 19, 2017 , ... ... hands of a doctor who administered fillers that resulted in severe facial disfiguration. ... case was taken on by doctors at UCLA Medical Center, who removed the ...
Breaking Medicine News(10 mins):